Earnings Feed
Start Free
Home/Filings/3/0001209191-23-047509
3//SEC Filing

Versant Side Fund III, L.P. 3

Accession 0001209191-23-047509

CIK 0001516551other
View on SEC.govCompany Profile

Filed

Aug 27, 8:00 PM ET

Accepted

Aug 28, 4:16 PM ET

Size

11.7 KB

Accession

0001209191-23-047509

Insider Transaction Report

Form 3
Period: 2023-08-18
Skye Bioscience, Inc.SKYE
Versant Ventures III, LLC
10% Owner
Holdings

  • Common Stock

    (indirect: By Versant Side Fund III, L.P.)
    2,946,924

  • Warrant (Right to Buy)

    (indirect: By Versant Venture Capital III, L.P.)
    Exercise: $0.02From: 2023-08-18Exp: 2033-08-18→ Common Stock (130,043,230 underlying)

  • Warrant (Right to Buy)

    (indirect: By Versant Side Fund III, L.P.)
    Exercise: $0.02From: 2023-08-18Exp: 2033-08-18→ Common Stock (768,124 underlying)

  • Common Stock

    (indirect: By Versant Venture Capital III, L.P.)
    498,978,878
Footnotes (2)
  • [F1]Securities are directly held by Versant Venture Capital III, L.P. ("Versant III"). Versant Ventures III, LLC ("Versant Ventures III") is the sole general partner of Versant III and may be deemed to share voting and dispositive power over the securities held by Versant III. Versant Ventures III disclaims beneficial ownership of such securities, except to the extent of its pecuniary interest therein.
  • [F2]Securities are directly held by Versant Side Fund III, L.P. ("Side Fund III"). Versant Ventures III is the sole general partner of Side Fund III and may be deemed to share voting and dispositive power over the securities held by Side Fund III. Versant Ventures III disclaims beneficial ownership of such securities, except to the extent of its pecuniary interest therein.

Documents

1 file

Issuer

Skye Bioscience, Inc.

CIK 0001516551

→
Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001456585

Filing Metadata

Form type
3
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 4:16 PM ET
Size
11.7 KB
View on SEC.gov